Brian Finrow is CEO and co-founder of Lumen Bioscience, a Seattle-based, clinical-stage biotechnology company developing biologic drugs for highly prevalent diseases. Lumen’s unique drug development and manufacturing platform offers the potential to transform the biologics industry through increased speed, mass-market scale, and exponentially lower costs than current approaches. Brian started his career practicing law out of Harvard Law School as a corporate lawyer representing biotech companies for 10 years, his entry into the industry. Prior to founding Lumen was on the senior executive team of Adaptive Biotechnologies where he oversaw corporate development and legal affairs.
Speaking In
9:45 AM - 10:00 AM (EST)
Monday, February 6
Lumen Bioscience discovers, develops, and manufactures biologic drug candidates for highly…
Winter Garden